All Curated Mutation Sites in IV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in IV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
HA1
  
HA2
  
M1
  
M2
  
NA
  
NP
  
NS1
  
NS2
  
PA
  
PB1
  
PB2
  

Keyword: Influenza A-39507787
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 39507787 A61F
NA
NA
Influenza A
G
S
L
View
2 39507787 A61R
NA
NA
Influenza A
G
S
L
View
3 39507787 A62F
NA
NA
Influenza A
G
S
L
View
4 39507787 A62R
NA
NA
Influenza A
G
S
L
View
5 39507787 A63F
NA
NA
Influenza A
G
S
L
View
6 39507787 A63R
NA
NA
Influenza A
G
S
L
View
7 39507787 D701N
PB2
PB2
Influenza A
G
S
L
View
8 39507787 E627K
PB2
PB2
Influenza A
G
S
L
View
9 39507787 Q591K
PB2
PB2
Influenza A
G
S
L
View
10 39507787 K356R
PA
PA
Influenza A
G
S
L
View
11 39507787 N319K
NP
NP
Influenza A
G
S
L
View
12 39507787 E119V
NA
NA
Influenza A
G
S
L
View
13 39507787 I222L
NA
NA
Influenza A
G
S
L
View
14 39507787 R292K
NA
NA
Influenza A
G
S
L
View
15 39507787 D92E
M2
M
Influenza A
G
S
L
View
16 39507787 G34E
M2
M
Influenza A
G
S
L
View
17 39507787 L26F
M2
M
Influenza A
G
S
L
View
18 39507787 S31N
M2
M
Influenza A
G
S
L
View
19 39507787 V27A
M2
M
Influenza A
G
S
L
View
20 39507787 G228S
HA
HA
Influenza A
G
S
L
View
21 39507787 Q226L
HA
HA
Influenza A
G
S
L
View
Contents
Description

The table shows all curated mutation sites of IV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.